このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Alkem Laboratories バランスシートの健全性
財務の健全性 基準チェック /66
Alkem Laboratoriesの総株主資本は₹107.1B 、総負債は₹12.1Bで、負債比率は11.3%となります。総資産と総負債はそれぞれ₹155.7Bと₹48.6Bです。 Alkem Laboratoriesの EBIT は₹19.5Bで、利息カバレッジ比率17.3です。現金および短期投資は₹17.3Bです。
主要情報
11.3%
負債資本比率
₹12.14b
負債
| インタレスト・カバレッジ・レシオ | 17.3x |
| 現金 | ₹17.28b |
| エクイティ | ₹107.14b |
| 負債合計 | ₹48.61b |
| 総資産 | ₹155.75b |
財務の健全性に関する最新情報
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Recent updates
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Feb 08Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?
Jan 09Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Nov 30Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly
Nov 17I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut
Sep 07Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise
Aug 20Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00
Aug 03Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Jul 19Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jul 01財務状況分析
短期負債: ALKEMの 短期資産 ( ₹104.1B ) が 短期負債 ( ₹39.9B ) を超えています。
長期負債: ALKEMの短期資産 ( ₹104.1B ) が 長期負債 ( ₹8.7B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ALKEM総負債よりも多くの現金を保有しています。
負債の削減: ALKEMの負債対資本比率は、過去 5 年間で16.8%から11.3%に減少しました。
債務返済能力: ALKEMの負債は 営業キャッシュフロー によって 十分にカバー されています ( 160.5% )。
インタレストカバレッジ: ALKEMの負債に対する 利息支払い は EBIT ( 17.3 x coverage) によって 十分にカバーされています。